论文部分内容阅读
目的：观察低分子肝素钙联合灯盏花素治疗老年肺心病患者的临床效果。方法选择2015年8月~2016年8月在本院进行治疗的老年肺心病患者80例，随机将其分为观察组和对照组两组各40例，两组患者均给予常规治疗，对照组患者在此基础上给予低分子肝素钙治疗，观察组患者在此基础给予低分子肝素钙联合灯盏花素治疗，比较两组患者的临床治疗效果。结果经治疗，观察组的治疗有效率和血流动力学变化均明显高于对照组，两组相比差异具有显著性（P＜0.05）；治疗后，两组患者的血浆黏度、纤维蛋白原以及红细胞比容均有所变化，且观察组变化程度明显高于对照组，且两组相比差异具有显著性（P＜0.05）。结论低分子肝素钙联合灯盏花素应用于老年肺心病患者的治疗中疗效确切，有助于改善患者临床症状，降低血浆粘度，对于提高患者预后具有积极意义。“,”Objective To observe the clinical effect of low molecular weight heparin calcium combined with breviscapine in the treatment of senile pulmonary heart disease.Methods 80 cases of patients with Elderly patients with pulmonary heart disease in our hospital from August 2015 to August 2016 were selected,divided into the observation group and the control group,each were 40 examples,two groups of patients were given conventional treatment, on this basis,the control group patients were given low molecular weight heparin calcium therapy, the observation group patients were given low molecular weight heparin calcium combined with breviscapine treatment, compared the two groups of patients with clinical treatment. Results After treatment, the effective treatment and hemodynamic changes of the observation group were significantly higher than the control group, and the difference between the two groups was significant, (P<0.05).Conclusion Low molecular weight heparin calcium combined with breviscapine in elderly patients with pulmonary heart disease in the treatment of effective, help to improve clinical symptoms and reduce plasma viscosity, for improving the prognosis of patients with positive significance.